Skip header and navigation

Narrow By

44 records – page 1 of 3.

Nova Scotia Health Authority. QEII. GI/General Surgery staff. Halifax, NS: Nova Scotia Health Authority , 2021.
Pamphlet Number
0046
Available Online
View Pamphlet
Your doctor has arranged for you to have bowel surgery. During surgery, a part of your bowel will be removed. This pamphlet will answer some of your questions about your stay in the hospital and care at home. An overview of what will happen before and after surgery is provided. Topics include: activity after surgery, nutrition, controlling discomfort, and care of your incision. Instructions for follow-up care are given. A list of symptoms that require you to call your surgeon's office or your p…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. QEII. GI/General Surgery staff
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2021
Format
Pamphlet
Language
English
Physical Description
1 electronic document (13 p.) : digital, PDF file
Subjects (MeSH)
Intestines - surgery
Colectomy
Colostomy
Subjects (LCSH)
Intestines--Surgery
Colectomy
Colostomy
Abstract
Your doctor has arranged for you to have bowel surgery. During surgery, a part of your bowel will be removed. This pamphlet will answer some of your questions about your stay in the hospital and care at home. An overview of what will happen before and after surgery is provided. Topics include: activity after surgery, nutrition, controlling discomfort, and care of your incision. Instructions for follow-up care are given. A list of symptoms that require you to call your surgeon's office or your primary health care provider are listed.
Responsibility
Prepared by: GI/General Surgery staff
Pamphlet Number
0046
Less detail

Laparoscopic bowel surgery

https://libcat.nshealth.ca/en/permalink/chpams35662
Nova Scotia Health Authority. QEII. GI/General Surgery staff. Halifax, NS: Nova Scotia Health Authority , 2021.
Pamphlet Number
0933
Available Online
View Pamphlet
Your doctor has arranged for you to have laparoscopic bowel surgery. During surgery, a part of your bowel will be removed using a laparoscope. Laparoscopic surgery has fewer complications than open bowel surgery. An overview of what will happen before and after surgery is provided. Topics include: nutrition, controlling discomfort, and care of your incision. Instructions for follow-up care are given. A list of symptoms that require you to call your surgeon's office or your primary health care p…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. QEII. GI/General Surgery staff
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2021
Format
Pamphlet
Language
English
Physical Description
1 electronic document (10 p.) : digital, PDF file
Subjects (MeSH)
Intestines - surgery
Laparoscopy
Subjects (LCSH)
Intestines--Surgery
Laparoscopic surgery
Abstract
Your doctor has arranged for you to have laparoscopic bowel surgery. During surgery, a part of your bowel will be removed using a laparoscope. Laparoscopic surgery has fewer complications than open bowel surgery. An overview of what will happen before and after surgery is provided. Topics include: nutrition, controlling discomfort, and care of your incision. Instructions for follow-up care are given. A list of symptoms that require you to call your surgeon's office or your primary health care provider are listed.
Responsibility
Prepared by: GI/General Surgery staff
Pamphlet Number
0933
Less detail

Risankizumab (Skyrizi®) therapy for inflammatory bowel disease (IBD)

https://libcat.nshealth.ca/en/permalink/chpams38191
Nova Scotia Health Authority. Nova Scotia Collaborative Inflammatory Bowel Disease Program. Halifax, NS: Nova Scotia Health Authority , 2023.
Pamphlet Number
2345
Available Online
View Pamphlet
Risankizumab is a biologic medication. A biologic medication is a type of medication that treats inflammation. This pamphlet explains how risankizumab works, how it is given, and how long you can expect to take it. Precautions, side effects, and what to expect after treatment are explained. Side effects that require contacting your primary health care provider are listed.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Nova Scotia Collaborative Inflammatory Bowel Disease Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2023
Format
Pamphlet
Language
English
Physical Description
1 electronic document (9 p.) : digital, PDF file
Subjects (MeSH)
Inflammatory Bowel Diseases - drug therapy
Subjects (LCSH)
Inflammatory bowel diseases
Specialty
Gastrointestinal System
Medications
Abstract
Risankizumab is a biologic medication. A biologic medication is a type of medication that treats inflammation. This pamphlet explains how risankizumab works, how it is given, and how long you can expect to take it. Precautions, side effects, and what to expect after treatment are explained. Side effects that require contacting your primary health care provider are listed.
Responsibility
Prepared by: Nova Scotia Collaborative IBD Program
Pamphlet Number
2345
Less detail

Corticosteroid therapy in inflammatory bowel disease (IBD)

https://libcat.nshealth.ca/en/permalink/chpams35480
Nova Scotia Health Authority. Nova Scotia Collaborative Inflammatory Bowel Disease Program. Halifax, NS: Nova Scotia Health Authority , 2021.
Pamphlet Number
1546
Available Online
View Pamphlet
Corticosteroids (kor-ti-koh-STER-oids) are strong inhibitors of inflammation (swelling). To ‘inhibit’ means to slow down or cut down on something. This pamphlet explains what corticosteriods do, how they work, when they are used, and how they are given. Precautions, side effects, and what to expect after treatment are explained. Side effects that require contacting your primary health care provider are listed.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Nova Scotia Collaborative Inflammatory Bowel Disease Program
Alternate Title
Corticosteroid therapy in IBD
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2021
Format
Pamphlet
Language
English
Physical Description
1 electronic document (9 p.) : digital, PDF file
Subjects (MeSH)
Inflammatory Bowel Diseases - drug therapy
Prednisone
Subjects (LCSH)
Inflammatory bowel diseases
Prednisone
Specialty
Gastrointestinal System
Medications
Abstract
Corticosteroids (kor-ti-koh-STER-oids) are strong inhibitors of inflammation (swelling). To ‘inhibit’ means to slow down or cut down on something. This pamphlet explains what corticosteriods do, how they work, when they are used, and how they are given. Precautions, side effects, and what to expect after treatment are explained. Side effects that require contacting your primary health care provider are listed.
Notes
This pamphlet replaced pamphlet 1139, Prednisone Therapy.
Responsibility
Prepared by: Nova Scotia Collaborative Inflammatory Bowel Disease Program
Pamphlet Number
1546
Less detail

Infliximab therapy for inflammatory bowel disease (IBD)

https://libcat.nshealth.ca/en/permalink/chpams34944
Nova Scotia Health Authority. Nova Scotia Collaborative IBD Program. Halifax, NS: Nova Scotia Health Authority , 2022.
Pamphlet Number
1140
Available Online
View Pamphlet
Your health care provider feels that treatment with infliximab may help you to manage your inflammatory bowel disease (IBD). This pamphlet describes what infliximab is and some important aspects of therapy with this medication. Precautions and possible side effects are listed.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Nova Scotia Collaborative IBD Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2022
Format
Pamphlet
Language
English
Physical Description
1 electronic document (12 p.) : digital, PDF file
Subjects (MeSH)
Inflammatory Bowel Diseases - drug therapy
Infliximab
Subjects (LCSH)
Inflammatory bowel diseases
Infliximab
Abstract
Your health care provider feels that treatment with infliximab may help you to manage your inflammatory bowel disease (IBD). This pamphlet describes what infliximab is and some important aspects of therapy with this medication. Precautions and possible side effects are listed.
Notes
Previous title: Infliximab (Remicade) therapy
Responsibility
Prepared by: Nova Scotia Collaborative IBD Program
Pamphlet Number
1140
Less detail

Adalimumab therapy for inflammatory bowel disease (IBD)

https://libcat.nshealth.ca/en/permalink/chpams35127
Nova Scotia Health Authority. Nova Scotia Collaborative IBD Program. Halifax, NS: Nova Scotia Health Authority , 2022.
Pamphlet Number
1207
Available Online
View Pamphlet
Your health care provider feels that treatment with adalimumab may help you manage your inflammatory bowel disease (IBD). This pamphlet describes what adalimumab is and some important aspects of therapy with this medication. Precautions and possible side effects are listed.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Nova Scotia Collaborative IBD Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2022
Format
Pamphlet
Language
English
Physical Description
1 electronic document (11 p.) : digital, PDF file
Subjects (MeSH)
Adalimumab
Inflammatory Bowel Diseases - drug therapy
Subjects (LCSH)
Inflammatory bowel diseases
Specialty
Medications
Abstract
Your health care provider feels that treatment with adalimumab may help you manage your inflammatory bowel disease (IBD). This pamphlet describes what adalimumab is and some important aspects of therapy with this medication. Precautions and possible side effects are listed.
Notes
Previous title: Adalimumab (Humira) therapy
Responsibility
Prepared by: Nova Scotia Collaborative IBD Program
Pamphlet Number
1207
Less detail

Golimumab (Simponi®) for inflammatory bowel disease (IBD)

https://libcat.nshealth.ca/en/permalink/chpams35651
Nova Scotia Health Authority. Nova Scotia Collaborative IBD Program. Halifax, NS: Nova Scotia Health Authority , 2022.
Pamphlet Number
1641
Available Online
View Pamphlet
Your health care provider feels that treatment with golimumab may help you manage your inflammatory bowel disease (IBD). This pamphlet describes what golimumab is and some important aspects of therapy with this medication. Precautions and possible side effects are listed.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Nova Scotia Collaborative IBD Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2022
Format
Pamphlet
Language
English
Physical Description
1 electronic document (12 p.) : digital, PDF file
Subjects (MeSH)
Golimumab
Inflammatory Bowel Diseases - drug therapy
Subjects (LCSH)
Inflammatory bowel diseases
Specialty
Medications
Abstract
Your health care provider feels that treatment with golimumab may help you manage your inflammatory bowel disease (IBD). This pamphlet describes what golimumab is and some important aspects of therapy with this medication. Precautions and possible side effects are listed.
Notes
Previous title: Golimumab (Simponi) therapy
Responsibility
Prepared by: Nova Scotia Collaborative IBD Program
Pamphlet Number
1641
Less detail

Nutrition guidelines after bowel surgery

https://libcat.nshealth.ca/en/permalink/chpams35317
Nova Scotia Health Authority. Nutrition and Food Services. Halifax, NS: Nova Scotia Health Authority , 2021.
Pamphlet Number
1415
Available Online
View Pamphlet
This pamphlet provides guidelines for the first 4 weeks (1 month) after bowel surgery. They will help with your healing, comfort, and bowel function. Foods that are best tolerated and foods to avoid are listed.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Nutrition and Food Services
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2021
Format
Pamphlet
Language
English
Physical Description
1 electronic document (4 p.) : digital, PDF file
Subjects (MeSH)
Gastrointestinal Diseases - diet therapy
Postoperative Care
Subjects (LCSH)
Postoperative care
Gastrointestinal system
Specialty
Food and nutrition
Abstract
This pamphlet provides guidelines for the first 4 weeks (1 month) after bowel surgery. They will help with your healing, comfort, and bowel function. Foods that are best tolerated and foods to avoid are listed.
Responsibility
Nutrition and Food Services
Pamphlet Number
1415
Less detail

Methotrexate (MTX) therapy for inflammatory bowel disease (IBD)

https://libcat.nshealth.ca/en/permalink/chpams34942
Nova Scotia Health Authority. Nova Scotia Collaborative Inflammatory Bowel Disease Program. Halifax, NS: Nova Scotia Health Authority , 2021.
Pamphlet Number
1138
Available Online
View Pamphlet
Your health care provider feels that treatment with methotrexate (meth-oh-TREX-ate) might help your Crohn’s disease or ulcerative colitis. These are both types of inflammatory bowel disease (IBD). This pamphlet explains what methotrexate (MTX) is, how well it works, side effects of MTX, who should not take MTX, and precautions. Instructions for injecting MTX are given.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Nova Scotia Collaborative Inflammatory Bowel Disease Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2021
Format
Pamphlet
Language
English
Physical Description
1 electronic document (13 p.) : digital, PDF file
Subjects (MeSH)
Methotrexate
Crohn's disease
Inflammatory Bowel Diseases
Immunosuppressive Agents
Subjects (LCSH)
Crohn's disease
Methotrexate
Immunosuppressive agents
Inflammatory bowel diseases
Specialty
Gastrointestinal System
Medications
Abstract
Your health care provider feels that treatment with methotrexate (meth-oh-TREX-ate) might help your Crohn’s disease or ulcerative colitis. These are both types of inflammatory bowel disease (IBD). This pamphlet explains what methotrexate (MTX) is, how well it works, side effects of MTX, who should not take MTX, and precautions. Instructions for injecting MTX are given.
Responsibility
Prepared by: Nova Scotia Collaborative Inflammatory Bowel Disease Program
Pamphlet Number
1138
Less detail

Nutrition guidelines for irritable bowel syndrome (IBS)

https://libcat.nshealth.ca/en/permalink/chpams37558
Nova Scotia Health Authority. Nutrition and Food Services. Halifax, NS: Nova Scotia Health Authority , 2022.
Pamphlet Number
0129
Available Online
View Pamphlet
Irritable Bowel Syndrome (IBS) is a change in how food and digestive juices move through the bowels. This can be too fast, too slow, or both too fast and too slow. This pamphlet explains the symptoms of IBS, how it is treated, and what you can do to help your symptoms. Information about keeping a food symptom diary is included.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Nutrition and Food Services
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2022
Format
Pamphlet
Language
English
Physical Description
1 electronic document (16 p.) : digital, PDF file
Subjects (MeSH)
Irritable Bowel Syndrome - diet therapy
Subjects (LCSH)
Irritable colon
Abstract
Irritable Bowel Syndrome (IBS) is a change in how food and digestive juices move through the bowels. This can be too fast, too slow, or both too fast and too slow. This pamphlet explains the symptoms of IBS, how it is treated, and what you can do to help your symptoms. Information about keeping a food symptom diary is included.
Notes
Previous title: Diet & Irritable Bowel Syndrome (IBS)
Responsibility
Prepared by: Nutrition and Food Services
Pamphlet Number
0129
Less detail

Ulcerative proctitis

https://libcat.nshealth.ca/en/permalink/chpams35311
Nova Scotia Health Authority. GI Clinic. Halifax, NS: Nova Scotia Health Authority , 2021.
Pamphlet Number
1422
Available Online
View Pamphlet
Ulcerative proctitis is a type of inflammatory bowel disease. Inflammatory bowel disease (IBD) is the general name for diseases that cause inflammation (swelling and irritation) in the intestines (“gut”). It includes ulcerative proctitis, Crohn’s disease, and ulcerative colitis. How this condition is diagnosed as well as the symptoms and treatments are reviewed.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. GI Clinic
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2021
Format
Pamphlet
Language
English
Physical Description
1 electronic document (4 p.) : digital, PDF file
Subjects (MeSH)
Colitis, Ulcerative
Inflammatory Bowel Diseases
Subjects (LCSH)
Ulcerative colitis
Inflammatory bowel diseases
Abstract
Ulcerative proctitis is a type of inflammatory bowel disease. Inflammatory bowel disease (IBD) is the general name for diseases that cause inflammation (swelling and irritation) in the intestines (“gut”). It includes ulcerative proctitis, Crohn’s disease, and ulcerative colitis. How this condition is diagnosed as well as the symptoms and treatments are reviewed.
Responsibility
Prepared by: GI Clinic
Pamphlet Number
1422
Less detail

5-Aminosalicylate (5-ASA) for inflammatory bowel disease (IBD)

https://libcat.nshealth.ca/en/permalink/chpams35397
Nova Scotia Health Authority. Nova Scotia Collaborative IBD Program. Halifax, NS: Nova Scotia Health Authority , 2022.
Pamphlet Number
1483
Available Online
View Pamphlet
5-aminosalicylate (5-ASA) is a medication often used to treat inflammatory bowel disease (IBD). It helps to controll active ulcerative colitis, or Crohn’s colitis and keep mild to moderate ulcerative colitis in remission (period of recovery). Topics include: what does 5-ASA do, which 5-ASA you should take, how to take 5-ASA, what other medications you can take, and how 5-ASA will help. The pamphlet also describes side effects and how long you will need to take 5-ASA.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Nova Scotia Collaborative IBD Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2022
Format
Pamphlet
Language
English
Physical Description
1 electronic document (5 p.) : digital, PDF file
Subjects (MeSH)
Inflammatory Bowel Diseases - drug therapy
Crohn Disease - drug therapy
Colitis - drug therapy
Subjects (LCSH)
Inflammatory bowel diseases
Crohn's disease
Colitis
Abstract
5-aminosalicylate (5-ASA) is a medication often used to treat inflammatory bowel disease (IBD). It helps to controll active ulcerative colitis, or Crohn’s colitis and keep mild to moderate ulcerative colitis in remission (period of recovery). Topics include: what does 5-ASA do, which 5-ASA you should take, how to take 5-ASA, what other medications you can take, and how 5-ASA will help. The pamphlet also describes side effects and how long you will need to take 5-ASA.
Notes
Previous title: 5-Aminosalicylate (5-ASA)
Responsibility
Prepared by: Nova Scotia Collaborative IBD Program
Pamphlet Number
1483
Less detail

Ustekinumab (Stelara) therapy

https://libcat.nshealth.ca/en/permalink/chpams35722
Nova Scotia Health Authority. Nova Scotia Collaborative IBD Program. Halifax, NS: Nova Scotia Health Authority , 2022.
Pamphlet Number
1695
Available Online
View Pamphlet
Your IBD health care provider believes treatment with a medication called ustekinumab may help to manage your inflammatory bowel disease (IBD). The brand name for ustekinumab is Stelara®. This pamphlet will give you basic information about ustekinumab to help you make an informed decision about whether or not to use this treatment. Topics include what ustekinumab is, how it works, how it is given, how long you will need to take it, and how much it will cost. Considerations before you start taki…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Nova Scotia Collaborative IBD Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2022
Format
Pamphlet
Language
English
Physical Description
1 electronic document (10 p.) : digital, PDF file
Subjects (MeSH)
Ustekinumab
Inflammatory Bowel Diseases - drug therapy
Subjects (LCSH)
Inflammatory bowel diseases
Crohn's disease
Ulcerative colitis
Specialty
Medications
Abstract
Your IBD health care provider believes treatment with a medication called ustekinumab may help to manage your inflammatory bowel disease (IBD). The brand name for ustekinumab is Stelara®. This pamphlet will give you basic information about ustekinumab to help you make an informed decision about whether or not to use this treatment. Topics include what ustekinumab is, how it works, how it is given, how long you will need to take it, and how much it will cost. Considerations before you start taking ustekinumab and while you are taking it are listed. Possible side effects, information about pregnancy and breast/chest feeding, and other important things to know are included.
Notes
Previous title: Ustekinumab (Stelara) therapy for Crohn's disease
Responsibility
Prepared by: Nova Scotia Collaborative IBD Program
Pamphlet Number
1695
Less detail

Bowel preparation for chronic kidney disease before colonoscopy

https://libcat.nshealth.ca/en/permalink/chpams35387
Nova Scotia Health Authority. Renal Program, Nova Scotia Health Authority. Pharmacy Services. Halifax, NS: Nova Scotia Health Authority , 2020.
Pamphlet Number
1475
Available Online
View Pamphlet
This pamphlet describes how to get ready for a colonoscopy if you have chronic kidney disease. Steps to prepare solutions on the day before your colonoscopy are listed. The day before your procedure and on the day of the test you should drink only clear liquids, and a suggested list is included. Remember not to eat any food or drink milk, or other liquids that are not clear, on the day before your colonoscopy or on the day of the test.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Nova Scotia Health Authority. Pharmacy Services
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2020
Format
Pamphlet
Language
English
Physical Description
1 electronic document (5 p.) : digital, PDF file
Subjects (MeSH)
Cathartics
Colonoscopy
Renal Insufficiency, Chronic
Subjects (LCSH)
Laxatives
Colonoscopy
Chronic renal failure
Specialty
Medications
Nephrology
Abstract
This pamphlet describes how to get ready for a colonoscopy if you have chronic kidney disease. Steps to prepare solutions on the day before your colonoscopy are listed. The day before your procedure and on the day of the test you should drink only clear liquids, and a suggested list is included. Remember not to eat any food or drink milk, or other liquids that are not clear, on the day before your colonoscopy or on the day of the test.
Responsibility
Prepared by: NSHA Renal Program Educators and Pharmacists
Pamphlet Number
1475
Less detail

Azathioprine and Mercaptopurine Therapy

https://libcat.nshealth.ca/en/permalink/chpams35565
Nova Scotia Health Authority. Nova Scotia Collaborative Inflammatory Bowel Disease Program. Halifax, NS: Nova Scotia Health Authority , 2021.
Pamphlet Number
1079
Available Online
View Pamphlet
This pamphlet will help you decide if azathioprine (Imuran®) or mercaptopurine therapy is right for you. The pamphlet explains what azathioprine (AZA) and mercaptopurine (6-MP) are, how well they work, as well as serious and less serious side-effects. The pamphlet also includes a list of what you can do to lower the chances of side-effects.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Nova Scotia Collaborative Inflammatory Bowel Disease Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2021
Format
Pamphlet
Language
English
Physical Description
1 electronic document (6 p.): digital, PDF file
Subjects (MeSH)
Immunosuppressive Agents
Azathioprine
Mercaptopurine
Subjects (LCSH)
Immunosuppressive agents
Specialty
Medications
Abstract
This pamphlet will help you decide if azathioprine (Imuran®) or mercaptopurine therapy is right for you. The pamphlet explains what azathioprine (AZA) and mercaptopurine (6-MP) are, how well they work, as well as serious and less serious side-effects. The pamphlet also includes a list of what you can do to lower the chances of side-effects.
Notes
Previous title: Azathioprine (Imuran) therapy
Responsibility
Prepared by: Nova Scotia Collaborative Inflammatory Bowel Disease Program
Pamphlet Number
1079
Less detail

[Colonoscopy : VG site]

https://libcat.nshealth.ca/en/permalink/chpams35393
Nova Scotia Health Authority. QEII. GI Unit. Halifax, NS: Nova Scotia Health Authority , 2018.
Pamphlet Number
1479
Available Online
View Pamphlet
This is an Arabic translation of the English pamphlet 0211. A colonoscopy is an exam of the large bowel (also known as the large intestine or colon). The doctor uses a special tube (endoscope) with a small light and camera on the end that bends to look for any changes on the inside of your large bowel. This pamphlet describes getting ready for the test, how the test is done, what polyps are, care after the test, and possible complications. If you are given sedation, you must not do certain acti…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. QEII. GI Unit
Alternate Title
Colonoscopy : Victoria General site
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2018
Format
Pamphlet
Language
Arabic
Physical Description
1 electronic document (10 p.) : digital, PDF file
Subjects (MeSH)
Colonoscopy
Colon
Endoscopes
Subjects (LCSH)
Colonoscopy
Colon
Endoscopes
Abstract
This is an Arabic translation of the English pamphlet 0211. A colonoscopy is an exam of the large bowel (also known as the large intestine or colon). The doctor uses a special tube (endoscope) with a small light and camera on the end that bends to look for any changes on the inside of your large bowel. This pamphlet describes getting ready for the test, how the test is done, what polyps are, care after the test, and possible complications. If you are given sedation, you must not do certain activities for 24 hours after the test.
Responsibility
Prepared by: GI Unit, QEII
Pamphlet Number
1479
Less detail

[Flexible sigmoidoscopy]

https://libcat.nshealth.ca/en/permalink/chpams35392
Nova Scotia Health Authority. QEII. GI Unit. Halifax, NS: Nova Scotia Health Authority , 2018.
Pamphlet Number
1478
Available Online
View Pamphlet
This is an Arabic translation of the English pamphlet 0188. A flexible sigmoidoscopy is a test of part of the lower bowel (also known as the lower large intestine or the sigmoid). The doctor uses a special tube (endoscope) with a small light and camera on the end that bends to look at the inside of your lower bowel and rectum. This pamphlet describes getting ready for the test, how the test is doen, and care after the test. Possible complications and symptoms requiring immediate medical attenti…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. QEII. GI Unit
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2018
Format
Pamphlet
Language
Arabic
Physical Description
1 electronic document (6 p.) : digital, PDF file
Subjects (MeSH)
Sigmoidoscopy
Colon
Endoscopes, Gastrointestinal
Subjects (LCSH)
Sigmoidoscopy
Colon
Endoscopes
Specialty
Gastrointestinal System
Abstract
This is an Arabic translation of the English pamphlet 0188. A flexible sigmoidoscopy is a test of part of the lower bowel (also known as the lower large intestine or the sigmoid). The doctor uses a special tube (endoscope) with a small light and camera on the end that bends to look at the inside of your lower bowel and rectum. This pamphlet describes getting ready for the test, how the test is doen, and care after the test. Possible complications and symptoms requiring immediate medical attention after the test are noted. If sedation is given, you must avoid certain activities for 24 hours.
Responsibility
Prepared by: GI Unit, QEII
Pamphlet Number
1478
Less detail

Colonoscopie : site du VG

https://libcat.nshealth.ca/en/permalink/chpams35424
Nova Scotia Health Authority. QEII. GI Unit. Halifax, NS: Nova Scotia Health Authority , 2018.
Pamphlet Number
1506
Available Online
View Pamphlet
La colonoscopie est un examen du gros intestin (côlon). Le médecin utilise un endoscope (un tube souple muni d'une lumière à son extrémité) pour examiner l'intérieur du gros intestin. Nous décrivons comment vous préparer pour l'examen, comment l'examen est effectué, les soins après l'examen et les complications possibles. Des polypes peuvent être enlevés pendant l'examen. Si vous recevez un sédatif, il y a certaines activités que vous ne devez pas effectuer pendant 24 heures après l'examen. ; T…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. QEII. GI Unit
Alternate Title
Colonoscopy : VG site
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2018
Format
Pamphlet
Language
French
Physical Description
1 electronic document (9 p.) : digital, PDF file
Subjects (MeSH)
Colonoscopy
Colon
Endoscopes
Subjects (LCSH)
Colonoscopy
Colon
Endoscopes
Specialty
Gastrointestinal System
Abstract
La colonoscopie est un examen du gros intestin (côlon). Le médecin utilise un endoscope (un tube souple muni d'une lumière à son extrémité) pour examiner l'intérieur du gros intestin. Nous décrivons comment vous préparer pour l'examen, comment l'examen est effectué, les soins après l'examen et les complications possibles. Des polypes peuvent être enlevés pendant l'examen. Si vous recevez un sédatif, il y a certaines activités que vous ne devez pas effectuer pendant 24 heures après l'examen.
This is a French translation of the English pamphlet 0211, "Colonoscopy: VG Site". Colonoscopy is an examination of the large bowel (colon). The doctor uses an endoscope (a flexible tube with a light at the tip) to view the inside of the large bowel. We have described getting ready for the test, the test itself, care after, and possible complications. Polyps may be removed. If you are given sedation, you must not do certain activities for 24 hours after the test.
Responsibility
Prepared by: GI Unit, QEII
Pamphlet Number
1506
Less detail
Nova Scotia Health Authority. Emergency Services. Halifax, NS: Nova Scotia Health Authority , 2019.
Pamphlet Number
0692
Available Online
View Pamphlet
Constipation is when you don’t have bowel movements (poops) very often, or they are hard to pass. We also call this “being constipated.” This pamphlet explains common causes of constipation and lists things you can do to help. Symptoms that require immediate medical attention are provided. The French version of this pamphlet 2080, "Constipation", is also available.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Emergency Services
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2019
Format
Pamphlet
Language
English
Physical Description
1 electronic document (4 p.) : digital, PDF file
Subjects (MeSH)
Constipation - prevention & control
Subjects (LCSH)
Constipation
Specialty
Emergency
Abstract
Constipation is when you don’t have bowel movements (poops) very often, or they are hard to pass. We also call this “being constipated.” This pamphlet explains common causes of constipation and lists things you can do to help. Symptoms that require immediate medical attention are provided. The French version of this pamphlet 2080, "Constipation", is also available.
Responsibility
Prepared by: Emergency Services
Pamphlet Number
0692
Less detail

Colonoscopy : VG Site

https://libcat.nshealth.ca/en/permalink/chpams34299
Nova Scotia Health Authority. QEII. GI Unit. Halifax, NS: Nova Scotia Health Authority , 2024.
Pamphlet Number
0211
Available Online
View Pamphlet
A colonoscopy is a test to look at your large bowel. This pamphlet describes risks, getting ready for the test, how the test is done, and care after the test. The French version of this pamphlet 1506, "Colonoscopie", is also available. The Arabic version of this pamphlet, 1479, is also available.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. QEII. GI Unit
Alternate Title
Colonoscopy : Victoria General Site
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2024
Format
Pamphlet
Language
English
Physical Description
1 electronic document (9 p.) : digital, PDF file
Subjects (MeSH)
Colonoscopy
Colon
Endoscopes
Subjects (LCSH)
Colonoscopy
Colon
Endoscopes
Abstract
A colonoscopy is a test to look at your large bowel. This pamphlet describes risks, getting ready for the test, how the test is done, and care after the test. The French version of this pamphlet 1506, "Colonoscopie", is also available. The Arabic version of this pamphlet, 1479, is also available.
Responsibility
Prepared by: GI Unit, VG Site, QEII
Pamphlet Number
0211
Less detail

44 records – page 1 of 3.